Figure 6.
Effects of HLE on bone formation and oxidative stress in Aβ-injured osteoblastic MC3T3-E1 cells. (A) The bone mineralization nodule determined by Alizarin red staining; (B) intracellular ROS levels determined by flow cytometry; (C–E) relative expression of Nrf2, HO-1, NQO1, FxoO1 and SOD-2 determined by Western blotting (n = 3). (# p < 0.05, ## p < 0.01, compared with the CON group; * p < 0.05, ** p < 0.01 compared with the model group. Model group means osteoblasts only treated with Aβ).